Compositions and methods for treating anemia

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11324734
APP PUB NO 20180092892A1
SERIAL NO

15563169

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with non-dialysis dependent chronic kidney disease anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • AKEBIA THERAPEUTICS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chandorkar, Gurudatt Ajay Waltham, US 2 14
Ette, Ene Ikpong Framingham, US 2 14
Farzaneh-Far, Ramin Brookline, US 9 17
Hartman, Charlotte Suzanne Carmel, US 2 14
Inrig, Jula Kern Yorba Linda, US 2 0
Maroni, Bradley John Boston, US 2 14
Smith, Alexander Apex, US 65 323

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 10, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 10, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 10, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00